EUCTR2009-018258-43-IT进行中（未招募）不适用
SIB-GBM trial (Simultaneous Integrated Boost in Glioblastoma multiforme: hyprofractionated radiotherapy with concomitant boost and temozolomide, in glioblastoma RPA III and IV patients - SIB-GBM trial
AZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI0 个研究点开始时间: 2010年3月11日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age > 18 years. Histological diagnosis of GBM RPA class III or IV preoperative brain MRI postoperative brain MRI Informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •.brainstem or spinal cord lesions. .previous brain radiotherapy .previous malignant neoplasm
研究者
相似试验
已完成
1 期
IGRT treatment with simultaneous integrated boost as dose escalation for patients with cervical cancerC53Malignant neoplasm of cervix uteriCERVICAL CANCERDRKS00019044niversität von Pécs, Klinisches Zentrum, Onkotherapeutisches Institut14
招募中
不适用
Simultaneous Integrated Boost in Carbon Ion Radiotherapy for Head and Neck Adenoid Cystic CarcinomaCarcinoma, Adenoid CysticHead and Neck CancerNCT05733910CNAO National Center of Oncological Hadrontherapy42
Unknown
2 期
SIB in Upper Thoracic Esophageal Squamous Cell CarcinomaEsophageal Squamous Cell CarcinomaNCT04115618Fudan University65
尚未招募
2 期
Radiation dose escalation in esophageal cancers by advanced radiation techniqueCTRI/2020/09/028108ONE
已完成
3 期
Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.Acellular PertussisDiphtheriaTetanusNCT00263679GlaxoSmithKline321